UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033056
Receipt number R000037690
Scientific Title Consideration of the validity of Erector Spinae Plane Block to trunk surgery
Date of disclosure of the study information 2018/06/19
Last modified on 2020/08/17 13:55:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Consideration of the validity of Erector Spinae Plane Block to trunk surgery

Acronym

Consideration of the validity of ESPB to trunk surgery

Scientific Title

Consideration of the validity of Erector Spinae Plane Block to trunk surgery

Scientific Title:Acronym

Consideration of the validity of ESPB to trunk surgery

Region

Japan


Condition

Condition

breast surgery / spine surgery / laparoscopic colon resection

Classification by specialty

Gastrointestinal surgery Breast surgery Orthopedics

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

do ESPB where it seems effective to breast cancer, spine surgery and colon cancer, and estimate their validity.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

NRS to a post-operatively for 48 hours

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Erector Spinae Plane Block is performed before the surgery.

Interventions/Control_2

A usual analgesia is performed.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The breast surgery, spine surgery and colon cancer operation under the laparoscope performed at my hospital in the period.

Key exclusion criteria

(1) Patient of a breast cancer operation of both sides
(2) Patient of a vertebrae cervicales operation
(3) Patient with a pathological change which doesn't suit that a tap has skin in the tap part
(4) Patient with the past allergic to local anesthetics
(5) The emergency operation patient who can think operation of a hand skill is dangerous
(6) Additionally the patient who judged that a study person in charge was unsuitable as a subject

Target sample size

128


Research contact person

Name of lead principal investigator

1st name masateru
Middle name
Last name kumemura

Organization

Juntendo University Shizuoka Hospital

Division name

Anesthesiology

Zip code

4102295

Address

1129 Nagaoka. Izunokuni-city Shizuoka, 410-2295, Japan

TEL

055-948-3111

Email

m-kumemura@juntendo.ac.jp


Public contact

Name of contact person

1st name masateru
Middle name
Last name kumemura

Organization

Juntendo University Shizuoka Hospital

Division name

Anesthesiology

Zip code

4102295

Address

1129 Nagaoka. Izunokuni-city Shizuoka, 410-2295, Japan

TEL

055-948-3111

Homepage URL


Email

m-kumemura@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University Shizuoka Hospital

Institute

Department

Personal name



Funding Source

Organization

Juntendo University Shizuoka Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University Shizuoka Hospital

Address

1129 Nagaoka. Izunokuni-city Shizuoka, 410-2295, Japan

Tel

055-948-3111

Email

m-kumemura@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

114

Results

The 48-h NRS score was significantly lower in the ESPB group than in the non-ESPB group.

Results date posted

2020 Year 05 Month 02 Day

Results Delayed

Delay expected

Results Delay Reason

Because it is being submitted to an academic journal

Date of the first journal publication of results


Baseline Characteristics

The subjects were patients aged over 20 years old who underwent laparoscopic colorectal cancer surgery, breast cancer surgery, or spinal (thoracic vertebrae and lumbar spine) surgery under general anesthesia in the operating theater of our hospital between June 20, 2018 and February 7, 2019.

Participant flow

During the study period, 122 subjects met the inclusion criteria, and 114 subjects were randomized, resulting in 55 being assigned to the ESPB group and 59 to the non-ESPB group. In the ESPB group, 54 subjects, excluding one who discontinued due to procedural difficulty, underwent ESPB. Of them, three subjects were lost to follow-up (early discharge from the hospital in one case and unable to obtain NRS data in two cases), and the remaining 51 subjects were analyzed. All 59 subjects in the non-ESPB group were analyzed.

Adverse events

Regarding adverse reactions defined as secondary outcomes, one patient each in both groups complained of nausea, but there were no complaints of numbness of extremities or of itching.

Outcome measures

The primary outcome was the NRS scores at rest and on movement measured immediately and at 3, 6, 12, 24, and 48 h post-surgery. The presence or absence of nausea or vomiting, itching, and numbness of limbs were recorded as secondary outcomes.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 06 Month 05 Day

Date of IRB

2018 Year 06 Month 17 Day

Anticipated trial start date

2018 Year 06 Month 20 Day

Last follow-up date

2019 Year 02 Month 07 Day

Date of closure to data entry

2019 Year 04 Month 24 Day

Date trial data considered complete

2019 Year 04 Month 24 Day

Date analysis concluded

2019 Year 06 Month 18 Day


Other

Other related information



Management information

Registered date

2018 Year 06 Month 19 Day

Last modified on

2020 Year 08 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037690


Research Plan
Registered date File name
2020/05/02 ①研究計画書.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name
2020/05/02 espb_datasets_corrected.csv